Navigation Links
New Presentation Highlights Importance of In-Hospital Hyperglycemia Management and Appropriate Discharge Planning for Diabetes Patients
Date:9/24/2009

The transition from inpatient to outpatient care for patients with diabetes and critical illnesses is featured in a presentation and free downloadable slides on the Diabetes Best Practices website.

Somerville, NJ (PRWEB) September 24, 2009 -- "Discharge planning for patients with diabetes and critical illnesses should focus on self-care and give them the survival skills necessary to maintain glycemic control," says Dr. Frank Lavernia in a new presentation on the Diabetes Best Practices website (http://www.diabetesbestpractices.com ). Dr. Lavernia's slides are also available for free download on the website.

Treatment Planning for Post-discharge Patients with Diabetes is the title of Dr. Lavernia's presentation and he begins by emphasizing that the prevalence of hyperglycemia in hospitalized patients is high.

"Identifying hyperglycemia in new critically ill inpatients is a medical priority necessary to ensure optimal care and improve outcomes," according to Dr. Lavernia, who then goes on to outline in-hospital treatment options as well as options for discharge and post-hospital care.

Because insulin therapy is often necessary for effective glycemic control, Dr. Lavernia's presentation addresses the problem of patient barriers to initiating insulin therapy. The slides deal with "needle phobia" and other concerns of patients as well as outlining clinician concerns about insulin therapy in the treatment of type 2 diabetes.

"Problems with glycemic control can begin once a patient gets discharged because meals are no longer measured for caloric intake, physical activity may be limited and medications may be missed," points out Dr. Lavernia.

"It is important for the health care provider to understand the treatment history of the patient and the options for care moving forward," Dr. Lavernia concludes. His concluding summary also emphasizes the need to maintain glycemic control in post-discharge patients as it will also lower the risk of cardiovascular disease. However, Dr. Lavernia also cautions clinicians not to be "glucocentric" and to regularly monitor hypertension, lipid levels, and BMI.

Dr. Frank Lavernia practices at the North Broward Diabetes Center, North Broward Medical Center, Pompano Beach, Florida and is the founder of the Diabetes Center, Internal Medicine and Diabetes, Coconut Creek, Florida

The Diabetes Best Practices website is a collaborative project of the University of Medicine and Dentistry of New Jersey (UMDNJ) and Embryon and is supported by an educational grant from sanofi-aventis U.S.

The University of Medicine and Dentistry of New Jersey is the nation's largest health sciences university. UMDNJ-Center for Continuing and Outreach Education (UMDNJ-CCOE) is the university's accrediting unit sponsoring national and international continuing medical education for a wide range of healthcare professionals.

Embryon is a medical communications provider to the pharmaceutical industry.

###

Read the full story at http://www.prweb.com/releases/diabetes/hyperglycemia/prweb2926764.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
2. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
3. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
4. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
5. Haemonetics Webcast Presentation
6. Presentation at Bio Contact Quebec 2007
7. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
8. Accuray to Webcast Senior Management Presentations at Analyst Day Event
9. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
10. Exelixis Announces October 10 Webcast of Presentation at the 2007 Bio InvestorForum Conference
11. HMS Holdings Corp. Hosts Third Quarter 2007 Financial Teleconference and Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Apple Rehab Shelton Lakes , which specializes in the ... facility as part of a disaster drill on October 3rd. , Apple Rehab participated ... Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid Plan ...
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... 12, 2017 , ... Planet Fitness, one of the largest and fastest growing ... open a flagship location in Covington, LA at 401 N. U.S. Highway 190, in ... to Office Depot in the Holiday Square shopping center. Its location allows it to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: